

Fundamental dimension Equity attribute | VRTLeader $195.64▲+0.03% Cap $75.32BP/E 43.3x QuantScore63/100 | ABBNYPeer $82.09▼-1.45% Cap $148.5BP/E 29.8x QuantScore38/100 | DLEGFPeer $7.33▲+5.56% Cap $91.38BP/E 97.5x QuantScore47/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
23/100 |
31/100 |
24/100 |
Valuation Multiples, PEG & DCF upside | 48/100 | 46/100 | 14/100 |
Health Piotroski, Altman Z, leverage & liquidity | 69/100 | 72/100 | 90/100 |
Growth Revenue / earnings growth & margins | 76/100 | 34/100 | 61/100 |
Sentiment Analyst ratings, targets & revisions | 100/100 | 8/100 | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 43.3x | 29.8x | 97.5x |
Forward P/E (next FY) | 29.1x | 24.5x | — |
EV / EBITDA (TTM) | 29.7x | 19.6x | 69.8x |
Price / Sales | 6.6x | 4.0x | 12.3x |
Price / Free Cash Flow | 25.8x | 30.4x | 241.6x |
PEG ratio | 0.39 | 2.12 | 1.49 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 5 / 9 | 6 / 9 | 8 / 9 |
Altman Z-Score | 5.60 (Safe) | 5.06 (Safe) | 23.17 (Safe) |
Total debt / equity | 0.70 | 0.51 | 0.04 |
Quick ratio | 1.0x | 1.1x | 1.0x |
Interest coverage | 39.1x | 23.7x | 613.4x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +27.7% | +1.1% | +20.0% |
Net income growth YoY | +168.8% | +20.3% | +30.7% |
Gross margin (TTM) | 38.0% | 40.1% | 28.8% |
Operating margin (FY) | 18.5% | 18.2% | 13.3% |
FCF margin (FY) | 18.4% | 13.4% | 6.2% |
5. Trailing price performancePrice change over period |
1M return | -20.8% | -16.1% | -1.8% |
3M return | -33.1% | -15.0% | -22.5% |
6M return | -39.9% | -17.4% | -26.7% |
Year to date | +19.9% | +11.0% | -14.4% |
1Y return | +4.4% | +10.4% | +28.5% |
3Y return | +397.9% | +147.9% | +401.8% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $17.58 -91.0% premium | $32.27 -60.7% premium | $1.30 -82.2% premium |
Wall Street consensus target | $366.06 +87.1% · range $320.00–$500.00 | $58.00 -29.3% · range $58.00–$58.00 | — — |
Consensus stance | 90% Buy5% Hold5% Sell | 40% Buy52% Hold8% Sell | — |